ROWE JONATHAN,DUFFY KEVIN,CLIMAX JOHN,Rowe Jonathan,Duffy Kevin,Climax John
申请号：
SI201330140
公开号：
SI2762143T1
申请日:
2013.07.15
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
The present invention relates to the compositions, formulations and methods of treating fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and their sequelae by administration of 15-OHEPA.
